What We Stand For

The GlaxoSmithKline Foundation represents a vision shared by the people who work at GlaxoSmithKline. GSK's employees are members of families, organizations and communities who are concerned about the well-being of our Canadian society and believe that we cannot be isolated from the world in which we do business.

We make a difference

What We Stand For

The GlaxoSmithKline Foundation is guided by the conviction that we should help to make a positive difference to Canadians' quality of life.

We believe that positive differences can be made and we know that new solutions to difficult problems can be achieved outside of the laboratory, deep in the heart of our communities. This sense of possibility underscores all of The Foundation's work.

We work with you

We are not a large foundation, and we can't make a difference on our own. The GlaxoSmithKline Foundation and the organizations we support have formed creative and collaborative working relationships. These partnerships allow us to offer more than financial resources to important initiatives. When appropriate, we try to provide guidance, expertise, in-kind support and the volunteer involvement of GlaxoSmithKline employees.

The Foundation does recognize that GlaxoSmithKline also benefits from our community involvement - we are investing in the health of our future society. Through our partnerships, we are learning new approaches, gaining insights and continually evolving as both a Foundation and a corporation.

As a global organization, GSK wants and needs to engage actively on science and to be part of the global scientific community - and we want to continue to do so in a way that is credible and that builds trust with all our stakeholders, including regulators, healthcare professionals, physicians, payers, and patients. Alongside this, GSK has a responsibility to ensure transparent, credible rules of scientific engagement that enable trust and ensure our intentions and actions will be driven by our values of patient focus, transparency, respect and integrity.

GSK has proactively further strengthened its standards of transparency when engaging with stakeholders through the introduction of a rigorous set of global Principles and Standards, which GSK collectively calls ‘Scientific Engagement’. These Principles and Standards emphasize the distinction between non-promotional scientific dialogue with our stakeholders and legitimate promotional activity to support licensed products. These Standards have also been applied to the activities of The GSK Foundation.

As a result, the eligibility criteria for Foundation funding has been updated to reflect these principles such that for charitable organizations with a focus on a specific disease state, only those whose work is directly aligned to areas in which GSK has an approved medicine or product for market in Canada will be considered for funding.

The GSK Foundation continues to support registered Canadian charitable organizations that meet the eligibility criteria that do not have a focus on a specific disease state.

V-box

The Gift of Life

GlaxoSmithKline is a major donor of medical products to disaster relief efforts. But how does it get donated medicines to areas devastated by disaster?